1 hour ago
Thu 08th April 2021 | 06:40 AM
MOSCOW (UrduPoint News / Sputnik – 08th April, 2021) Russia’s EpiVacCorona vaccine is fully suitable for the re-vaccination against COVID-19, the director of the Vector research institute that developed the drug told Sputnik.
“The EpiVacCorona vaccine is fully suitable for the re-vaccination,” Rinat Maksyutov said.
EpiVacCorona is an antigens-based vaccine that was registered by the Russian government on October 13 and is underway with phase 3 clinical trials.
The drug is one of the three vaccines against the coronavirus developed in Russia, along with Sputnik V of Moscow’s Gamaleya Institute and CoviVac of the Chumakov research institute.